Xeris Biopharma Holdings, Inc. Share Price
XERSXeris Biopharma Holdings, Inc. Stock Performance
Open $8.55 | Prev. Close $8.70 | Circuit Range N/A |
Day Range $8.50 - $9.00 | Year Range $4.90 - $10.07 | Volume 99,678 |
Average Traded $8.84 |
Xeris Biopharma Holdings, Inc. Share Price Chart
About Xeris Biopharma Holdings, Inc.
Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase 3 clinical trial for the treatment of hypothyroidism. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.
Xeris Biopharma Holdings, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
17-Jul-26 | $8.55 | $8.80 | +1.15% |
16-Jul-26 | $8.70 | $8.70 | +0.12% |
15-Jul-26 | $8.21 | $8.69 | +5.08% |
14-Jul-26 | $8.15 | $8.27 | +1.47% |
13-Jul-26 | $8.35 | $8.15 | -2.45% |
10-Jul-26 | $8.59 | $8.36 | -3.19% |
09-Jul-26 | $8.63 | $8.63 | -0.52% |